Similar articles for PMID: 24528617

Year	Number of Results
1998	1
2006	1
2008	8
2009	7
2010	3
2011	8
2012	16
2013	26
2014	12
2015	8
2016	5
2017	8
2018	12
2019	6
2020	2
2021	1
2024	0

1

Unanswered questions in patients with concurrent atrial fibrillation and acute coronary syndrome.

Ice DS, Shapiro TA, Gnall EM, Kowey PR. Ice DS, et al. Am J Cardiol. 2014 Mar 1;113(5):888-96. doi: 10.1016/j.amjcard.2013.11.046. Epub 2013 Dec 12. Am J Cardiol. 2014. PMID: 24528617 Review.

2

Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.

Capodanno D, Angiolillo DJ. Capodanno D, et al. Circ Cardiovasc Interv. 2014 Feb;7(1):113-24. doi: 10.1161/CIRCINTERVENTIONS.113.001150. Circ Cardiovasc Interv. 2014. PMID: 24550531 Review. No abstract available.

3

New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.

Rubboli A, Agewall S, Huber K, Lip GY. Rubboli A, et al. Int J Cardiol. 2015 Oct 1;196:133-8. doi: 10.1016/j.ijcard.2015.06.006. Epub 2015 Jun 15. Int J Cardiol. 2015. PMID: 26093527 Review.

4

Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.

Cairns JA, McMurtry MS. Cairns JA, et al. Can J Cardiol. 2013 Jul;29(7 Suppl):S60-70. doi: 10.1016/j.cjca.2013.04.006. Can J Cardiol. 2013. PMID: 23790600 Review.

5

Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.

Helft G, Gilard M, Le Feuvre C, Zaman AG. Helft G, et al. Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):673-80. doi: 10.1038/ncpcardio0712. Nat Clin Pract Cardiovasc Med. 2006. PMID: 17122800 Review.

6

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.

Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset T, Kirchhof P, Marín F; European Society of Cardiology Working Group on Thrombosis. Lip GY, et al. Thromb Haemost. 2010 Jan;103(1):13-28. doi: 10.1160/TH09-08-0580. Epub 2009 Sep 30. Thromb Haemost. 2010. PMID: 20062939 Review.

7

Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.

Kar S, Bhatt DL. Kar S, et al. Coron Artery Dis. 2012 Sep;23(6):380-90. doi: 10.1097/MCA.0b013e328356490a. Coron Artery Dis. 2012. PMID: 22728913 Review.

8

Clopidogrel hydrogen sulphate for atrial fibrillation.

Garg N, Rajpurohit N, Flaker G. Garg N, et al. Expert Opin Pharmacother. 2011 Aug;12(11):1781-7. doi: 10.1517/14656566.2011.587118. Epub 2011 Jun 11. Expert Opin Pharmacother. 2011. PMID: 21663525 Review.

9

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY. Potpara TS, et al. Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Adv Ther. 2012. PMID: 22684583 Review.

10

Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits?

Asencio LA, Huang JJ, Alpert JS. Asencio LA, et al. Am J Med. 2014 Jul;127(7):579-85. doi: 10.1016/j.amjmed.2014.02.030. Epub 2014 Mar 6. Am J Med. 2014. PMID: 24608021 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

118 results

Results by year